42 HVAD® Instructions for Use
10
9
8
7
6
5
4
3
2
1
Appendix
Reference
Guides
Alarms and
Emergencies
Patient
Management
Surgical
Implant and
Explant
Monitor
Peripherals
and
Accessories
HVAD
®
Pump Overview
Introduction
1.9 Destination Therapy Supplemental Study (continued)
Table 19: Analyses of the Primary Endpoint
HVAD
Control
58 24
51 23
13 1
post-stroke
38 18
at 12 months
0 0
neurologic injury events at 12 months
45 (14.7%) 19 (12.1%)
Difference of neurologic injury incidence
2.6%
[-5.5%, 10.7%]
Fail
p-value
0.1444
Figure 16:
To Next Page
Loading...